ATE130008T1 - Für oligodendrocyten cytotoxischer faktor. - Google Patents

Für oligodendrocyten cytotoxischer faktor.

Info

Publication number
ATE130008T1
ATE130008T1 AT90116388T AT90116388T ATE130008T1 AT E130008 T1 ATE130008 T1 AT E130008T1 AT 90116388 T AT90116388 T AT 90116388T AT 90116388 T AT90116388 T AT 90116388T AT E130008 T1 ATE130008 T1 AT E130008T1
Authority
AT
Austria
Prior art keywords
oligodendrocytes
cytotoxic factor
factor
homologs
fragments
Prior art date
Application number
AT90116388T
Other languages
English (en)
Inventor
Michal Schwartz
Avi Cohen
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE130008T1 publication Critical patent/ATE130008T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/104Aminoacyltransferases (2.3.2)
    • C12N9/1044Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90116388T 1989-08-28 1990-08-27 Für oligodendrocyten cytotoxischer faktor. ATE130008T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL91459A IL91459A0 (en) 1989-08-28 1989-08-28 Oligodendrocyte inhibitory factor

Publications (1)

Publication Number Publication Date
ATE130008T1 true ATE130008T1 (de) 1995-11-15

Family

ID=11060333

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90116388T ATE130008T1 (de) 1989-08-28 1990-08-27 Für oligodendrocyten cytotoxischer faktor.

Country Status (16)

Country Link
EP (1) EP0415321B1 (de)
JP (1) JPH0411896A (de)
KR (1) KR910004200A (de)
AT (1) ATE130008T1 (de)
CA (1) CA2024030A1 (de)
DE (1) DE69023433T2 (de)
DK (1) DK0415321T3 (de)
ES (1) ES2081884T3 (de)
FI (1) FI904229A7 (de)
GR (1) GR3018534T3 (de)
HU (1) HUT56117A (de)
IE (1) IE903108A1 (de)
IL (1) IL91459A0 (de)
NZ (1) NZ235059A (de)
PT (1) PT95123A (de)
ZA (1) ZA906853B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97365A0 (en) * 1991-02-27 1992-05-25 Yeda Res & Dev Pharmaceutical compositions comprising a lymphokine
IE911318A1 (en) * 1990-04-23 1991-10-23 Yeda Res & Dev Use of a tumor necrosis factor for facilitating nerve¹regeneration
EP0610475B1 (de) * 1992-07-30 2002-03-20 Yeda Research And Development Company, Ltd. Aus nerven gewonnenes transglutaminase-enzym für die induktion der nervenregeneration
US5800812A (en) * 1995-09-15 1998-09-01 Yeda Research And Development Co. Ltd. Methods of use of mononuclear phagocytes to promote axonal regeneration
US6267955B1 (en) 1995-09-15 2001-07-31 Yeda Research And Development Co. Ltd. Mononuclear phagocytes and their use to promote axonal regeneration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71440A0 (en) * 1984-04-04 1984-07-31 Univ Ramot Composition for nerve regeneration
IL87349A (en) * 1988-08-04 1994-06-24 Michal Schwartz Water-soluble factor that activates glial cells, its preparation and pharmaceutical compositions comprising it

Also Published As

Publication number Publication date
FI904229A0 (fi) 1990-08-27
FI904229A7 (fi) 1991-03-01
IE903108A1 (en) 1991-03-13
ES2081884T3 (es) 1996-03-16
PT95123A (pt) 1991-05-22
EP0415321A1 (de) 1991-03-06
DE69023433D1 (de) 1995-12-14
KR910004200A (ko) 1991-03-28
DK0415321T3 (da) 1995-12-27
HU905507D0 (en) 1991-02-28
AU6137290A (en) 1991-02-28
EP0415321B1 (de) 1995-11-08
CA2024030A1 (en) 1991-03-01
HUT56117A (en) 1991-07-29
IL91459A0 (en) 1990-04-29
DE69023433T2 (de) 1996-04-04
GR3018534T3 (en) 1996-03-31
JPH0411896A (ja) 1992-01-16
NZ235059A (en) 1992-09-25
AU642897B2 (en) 1993-11-04
ZA906853B (en) 1991-06-26

Similar Documents

Publication Publication Date Title
ATE196089T1 (de) Mittel zur hemmung des komplementsystems hergestellt aus fucanen aus braunen algen
GR3035682T3 (en) Non-glycosylated fgf-4 and compositions containing the same.
IL85627A (en) Pharmaceutical compositions for treatment of disorders of ischemic origin comprising metformin and its salts
ES2054723T3 (es) Tetrahidropiridinoximas, procedimiento para su preparacion y uso de las mismas como agentes colinergicos.
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
PT89249A (pt) Processo para a preparacao de novos derivados de piperidinilo 1,4-dissubstituido com actividade terapeutica
PT91249A (pt) Processo para a preparacao de glicosaminoglicanos selectivamente o-acilados
ATE130008T1 (de) Für oligodendrocyten cytotoxischer faktor.
HU896609D0 (en) Process for the preparation of pharmaceutical compositions containing compounds having nootropic activity
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
GR3015052T3 (en) Antibiotic GE 2270 factors A1, A2, A3 and H.
DK0443848T3 (da) Nyt antiulcermiddel
ATE64300T1 (de) Wirkstoffe zur anwendung bei der behandlung von tumoren.
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
DE68927055D1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
ES2111561T3 (es) Derivados de benzopirano antihipertensivos.
MY130049A (en) Oligodendrocyte cytotoxic factor.
PT91415A (pt) Processo para a preparacao de novos derivados de furiltiazol
DK249288A (da) Substituerede silylalkylenaminer og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
PT95566A (pt) Metodo para a utilizacao de derivados de 2-oxindole substituidos na posicao 3 como inibidores da biossintese de interleuquina-1
DE58902310D1 (de) Tetrahydropyridin-derivate.
PT93822A (pt) Processo para a preparacao de derivados de piridina
BR9714184A (pt) Utilização de bonzoillquil-1,2,3,6-tetraidropiridinas
DE68909399D1 (de) Verwendung von Gangliosiden zur Behandlung der Dysfunktion des autonomen Nervensystems bei der Chagas-Krankheit.
DZ1230A1 (fr) Procédé de préparation des cis-n-(3-méthoxy-4-pipéridinyl benzamides.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee